急性髓系白血病社区管理策略数据表1
一份关于急性髓系白血病(AML)患者社区治疗与协同管理的综述PDF文件。

基本信息
资源简介
急性髓系白血病社区管理策略数据表1
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 1 个文件、合计 250.73 KB,主题涵盖 acute myeloid leukemia、community、diagnosis、management、treatment,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf》。配套论文《Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia》发表于 Blood(2019),DOI:10.1182/blood-2019-123717。源站首次发布:2022-12-12。
【数据内容】
源站原始描述:The treatment landscape for acute myeloid leukemia (AML) has changed substantially in recent years. The introduction of newer therapies, including oral agents, less myelosuppressive agents, and parenteral regimens suitable for outpatient administration, has made it feasible for select patients to receive therapy in the outpatient setting and in community practices. Thorough patient evaluation (including molecular testing), planned supportive care (eg, transfusion support, antimicrobial prophylax…
中文译文(机器翻译,仅供快速理解,请以原文为准):近年来,急性髓系白血病(AML)的治疗格局已发生实质性变化。包括口服药物、骨髓抑制较轻的药物以及适合门诊给药的非口服方案在内的新型疗法的引入,使部分患者能够在门诊和社区诊所接受治疗成为可能。无论是在社区还是在专业白血病中心,要成功管理患者,都需要多学科团队进行全面的患者评估(包括分子检测)、制定计划性支持治疗(如输血支持、抗微生物药物预防)以及警惕的患者监测(针对肿瘤溶解综合征和不良事件)。部分患者无法或不愿意前往较大的学术中心接受治疗,与位置较不便的学术中心/白血病中心相比,在社区环境中治疗AML可能具有潜在优势。这包括减轻患者及其家庭的经济负担,并且通常能为家庭/照护者支持提供更好的机会。此外,社区诊所与学术中心/白血病中心之间的合作对于优化许多患者的AML管理往往至关重要,因为协作可能有助于获得额外的专业知识和临床试验机会、支持治疗的多学科团队、更容易过渡到造血细胞移植,以及获得复杂的分子检测。在这篇综述中,我们讨论社区环境中的AML治疗与管理、可用的疗法,以及更强烈建议转诊至学术中心/白血病中心并与其共同管理的情形。
【数据结构与技术规格】
文件数 1 个,合计 250.73 KB。DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf:application/pdf,250.73 KB。数据集 DOI:10.3389/fonc.2022.1060912.s001。
【主题与分类】
源站学科分类:Cancer、Haematological Tumours、Molecular Targets、Radiation Therapy、Oncology and Carcinogenesis not elsewhere classified、Solid Tumours。主题标签:acute myeloid leukemia、community、diagnosis、management、treatment、hematopoietic cell transplantation。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Co-management_strategies_for_acute_myeloid_leukemia_patients_in_the_community_setting_pdf/21709244
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Benton, Christopher; Grunwald, Michael R.; Safah, Hana; Kasner, Margaret (2022). DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-21,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf
- DOI:10.3389/fonc.2022.1060912.s001
- 发布日期:2022-12-12
- 文件数:1 个
- 文件总体积:250.73 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Co-management_strategies_for_acute_myeloid_leukemia_patients_in_the_community_setting_pdf/21709244
命令行下载
curl -L -o "DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf" "https://ndownloader.figshare.com/files/38514416"
文件清单
DataSheet_1_Co-management strategies for acute myeloid leukemia patients in the community setting.pdf(250.73 KB)
文件总体积 250.73 KB(源站 API 实测)。
数据说明
The treatment landscape for acute myeloid leukemia (AML) has changed substantially in recent years. The introduction of newer therapies, including oral agents, less myelosuppressive agents, and parenteral regimens suitable for outpatient administration, has made it feasible for select patients to receive therapy in the outpatient setting and in community practices. Thorough patient evaluation (including molecular testing), planned supportive care (eg, transfusion support, antimicrobial prophylaxis), and vigilant patient monitoring (for tumor lysis syndrome and adverse events) by a multidisciplinary team are required for successful management of patients both in the community and at specialized leukemia centers. Some patients are unable or unwilling to travel to larger academic centers for treatment, and treatment of AML in the community setting may have potential advantages compared to less conveniently located academic/leukemia centers. This includes reduction of financial hardship for patients and their families and often better opportunities for family/caregiver support. Additionally, partnership between community practices and academic/leukemia centers is often crucial to optimizing AML management for many patients, as collaboration may facilitate access to additional expertise and trials, multidisciplinary teams for supportive care, easier transition to hematopoietic cell transplantation, and access to sophisticated molecular testing. In this review, we discuss AML treatment and management in the community setting, available therapies, and circumstances in which a referral to and co-management with an academic/leukemia center is more strongly recommended.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fonc.2022.1060912.s001(source: https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Co-management_strategies_for_acute_myeloid_leukemia_patients_in_the_community_setting_pdf/21709244)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




